Moderna Inc.

U.S.: Nasdaq
0.00
Real Time Quote
About Moderna Inc.
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was ...
See Full Profile

Average price target from 22 ratings: $216.55

Average score:

Sell
Under
Hold
Over
Buy
Full Ratings
Open
$121.00
Previous Close-
YTD Change
-32.93%
12 Month Change
-16.49%
Day Range118.44 - 121.32
52 Wk Range115.03 - 217.25
Volume
3.27M (99.18% of Avg)
65 Day Avg: 3.29M
Volume3.29M
Market Value$46.15B
Shares Outstanding381.21M
EPS (TTM)$11.59
P/E Ratio (TTM)10.40
Dividend YieldN/A
Latest DividendN/A
Ex-Dividend DateN/A
Beta0.62
Short Interest18.72M (05/31/23)
Short Interest Change2.74%
Percent of Float5.65%
Advanced

Peers

Name
Chg %
Market Cap
Johnson & Johnson
1.06%
$425.88B
Pfizer Inc.
-0.44%
$219.6B
AstraZeneca PLC ADR
0.21%
$228.63B
AstraZeneca PLC
-0.72%
£179.57B
GSK PLC
3.41%
£55.85B
BioNTech SE ADR
-0.14%
$25.9B
Biogen Inc.
-0.14%
$42.61B

Recently Viewed

Symbol
% Chg
Price

news

No data provided

People

Key Executives
Board Members
Stéphane Bancel MBA
Chief Executive Officer & Director
Noubar B Afeyan PhD
Chairman
Stephen Hoge MD
President
Francois Nader MD, EMBA
Independent Non-Executive Director
James M Mock
Chief Financial Officer
Sandra J Horning MD
Independent Director
See All on Company & People

Major Holders

No data provided
2022
Revenue
19.11B
Net Income
8.36B
Net Profit Margin
43.76%
2022
Total Assets
26.09B
Total Liabilities
6.96B
Debt to Assets
26.70%
2022
Operating
5B
Investing
-5.18B
Financing
-3.46B
See All Financials

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Source: FactSet

Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media